Pfizer Prevails in Singapore Trademark Dispute Over Vaccine Naming Tom Lees BitMine Executes Largest Ethereum Acquisition of 2026 UK Exports to US Plunge 25 Following Trump Tariff Blitz Trade Deficit Emerges UK Secures 37bn Trade Agreement with Six Gulf States Slashing 580m in Tariffs Companies Double Down on Prediction Market Investments Amid Regulatory Uncertainty SLI Q1 2026 Earnings Narrower Loss Beats Estimates as Lithium Developer Advances Projects LAW Q1 2026 Earnings EPS Beat Drives Stock Higher Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline CSGS Q1 2026 Earnings Solid EPS Beat Amidst Flat Market Reaction ING Q1 2026 Earnings EPS Beats Estimates by 66 as Net Interest Income Holds Steady Stock Declines abrdn Global Infrastructure Income Fund ASGI Holds Steady Near Midpoint of Range Liminatus Pharma LIMN Holds Steady at 018 Key Levels Define NearTerm Range Saratoga Investment Corp SAR Edges Lower in Quiet Session BioAge Labs BIOA Slightly Declines as Biotech Sector Faces Mixed Sentiment OSI Systems OSIS Holds Steady Above Support After Modest Gains QuantumScape QS Nears Key Support After 15 Decline What Traders Are Watching Delhi High Court Ruling Against Google Over Keyword Ads Signals Shift in Digital Advertising Landscape PDM Q1 2026 Earnings Significant EPS Miss Amid Challenging Conditions Hong Kong and Singapore Financial Sectors Face AIDriven Job Transformation SIP Boom May Aid FPI Exits and Add Pressure on Rupee Analysts Suggest FCBC Q1 2026 Earnings Slight EPS Miss Amid Flat Revenue Stock Inches Higher Brookfield Infrastructure Partners Gains 212 as Infrastructure Sector Shows Strength DAIO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions WEC Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower Magnite MGNI Q1 2026 Earnings EPS Beats Estimates by 206 on Improved Profitability BMNR Q1 2026 Earnings Positive EPS Surprise Amid No Revenue Disclosure FVCB Q1 2026 Earnings EPS Beats Estimates by Nearly 4 YALA Q1 2026 Earnings EPS of 016 Highlights Solid Performance Amid Limited Disclosures TEVA Q1 2026 Earnings EPS Beats Estimates by 878 as Generic Drugmaker Posts Strong Quarter